VSY Biotechnology took out a patent for a “Rotaryjet Preloaded Injector” enabling the easy, quick, and safe injection and implantation of intra-ocular lenses during cataract operations. The firm also became the owner of a patent for its new packing of intra-ocular lenses produced with biocompatible material that has strong sterilization characteristics.
In the “Rotaryjet Preloaded Injector,” which was invented and patented by VSY Biotechnology, the intraocular lens is ready to use. Thanks to the specially designed lens-folding system, intra-ocular lenses can be easily, quickly, and safely implanted into the eye during a cataract operation. The injector is offered with a different diopter range depending on the choice of the ophthalmologist. The new patent aims to reduce the rate of human-induced errors during the preparation of the intra-ocular lens before the operation and to facilitate the operation, resulting in a shorter operation time. The injector helps to enhance patient safety.
Another invention patented by VSY Biotechnology is “An enhanced biocompatible packing system: Vial system opened by breaking.” This system is a new packing system that brings the sterilization effect to the forefront in intro-ocular lenses. The one-piece packing system produced by a single biocompatible material helps ophthalmologists use intra-ocular lenses easily and safely.
VSY BIOTECHNOLOGY CEO OZGE ALTUNBAS GOKTEKİN:
“WE WILL CONTINUE ADDING NEW PATENTS TO OUR CORPORATION”
VSY Biotechnology CEO Özge Altunbaş Göktekin made the following statements about these patents: “As the VSY Biotechnology family, our vision is to become a global company, achieving sustainable development in its operations and producing products with the highest quality featuring advanced technology to support people’s life quality. In line with this vision, our innovation-based studies will continue. Thus, we will proceed to develop new products contributing to human health and incorporate new patents into our portfolio.”